Universitas Muhammadiyah Yogyakarta

Tampak depan Kampus terpadu Universitas Muhammadiyah Yogyakarta.

10 Cara Efektif Menurunkan Berat Badan dalam Seminggu

Ada pesta harus dihadiri seminggu lagi, dan Anda merasa gaun kesayangan dipakai ke pesta nanti lebih sempurna...

Keperawatan Medikal Bedah

Bersama kita bisa......

Go Abroad....

Program pasca sarjana UMY yang istimewa muda mendunia...

The Great University

UMY is most popular in yogyakarta....

Showing posts with label QUALITY. Show all posts
Showing posts with label QUALITY. Show all posts

Appendix XIII PRESERVATION OF CELL CULTURE MONOLAYERS & Appendix XIV QUALITY CONTROL OF CELL CULTURES USED FOR ROUTINE VIRUS ISOLATES

1. Aspirate the medium from the cell culture tubes to be preserved.

2. Add 8 mL buffered formaldehyde preservative medium to each tube.

3. Record the following information on the tube:

- virus

- number of days incubation

- lab number

4. Store preserved culture at room temperature.

Formaldehyde Preservative

100 mL Formaldehyde Solution (37 - 40%)

900 mL Distilled Water

20 mL Phenol Red (0.5%)

4.0 g NaH2PO4 - H2O

6.5 g Na2HPO4

Materials

Vortex

Sterile pipettes

10 - 100 uL Eppendorf pipette

Humidified chamber

Coplin jars

Fluorescent microscope

 

Appendix XIV

QUALITY CONTROL OF CELL CULTURES USED FOR ROUTINE VIRUS ISOLATES

Tube Culture (Not in routine use)

Upon receipt of cell culture tubes, the record of the date received, vendor, lot number, and passage number is kept in the QC binder for cell lines. The monolayer is checked microscopically for sterility and appearance of an acceptable confluent monolayer.

 

A. Uninoculated Negative Controls:

Reserve 4 tubes of each lot cells for use as controls and label as follows:

N1, date;

N2, date;

N3 date;

C, date;

V, date

 

a. Negative Controls with refeed: (3 tubes, N1; N2; N3)

Select one tube each on Wednesday Friday and Monday to set up along with inoculated specimens. Incubate, observe and refeed these tubes in parallel with patient inoculated cultures to monitor monolayer quality, toxicity and sterility. They can also be used to provide a baseline for comparison of inoculated cultures when reading for CPE and immunostaining. CMK and HFF tubes are kept for 3 weeks, HEp-2 and RD for 2 weeks

b. Unopened Negative Controls without refeed: (2 tubes, C; V)

These tubes are left unopened and observed to identify toxicity and contamination originating with the vendor. All tubes, CMK, HEp-2 , HFF and RD tubes are kept for only one week. One tube (C) is kept in the clean room and one (V) is placed on the Virology drum.

 

Record sterility and cell appearance for these tubes into the LIS Manual (REGISTRATION OF TUBE CULTURE MEDIA)

B. Positive Controls:

Each week scrape from an HFF tubes containing the following QC strains of HSV-1 HSV-2 and CMV to propagate the QC strains in the new lot of HFF tubes, Use CMK tubes for RSV and nfluenza A. Examine microscopically for CPE and record the results into the LIS as growth control. At the same time also inoculate MRC-5 and R-Mix shell vials to perform quality control for MRC-5 shell vials (see II. Shell Vial Cell Lines (MRC-5 cell suspension below)

HSV-1 (ATCC VR-5539)

HSV-2 (ATCC VR-540)

CMV (ATCC VR-807)

RSV (ATCC VR-284)

Influenza A (ATCC VR-544)

The MRC-5 shell vials are then stained with HSV-1, HSV-2 and CMV IEA monoclonal antibodies at 24 hours, R-Mix shell vials with RS. Record the results into the LIS as shell vial growth control as well as stain controls.

Each month (and whenever necessary), remove from the liquid nitrogen storage, cryovials of above strains to propagate the QC strains in HFF tubes.

Additional positive controls may be set up with the following strains and for the following reasons:

Coxsackie B1 (ATCC VR-28)

Parainflunza 3 (ATCC )

Varicella-zoster (ATCC VR-1367)

i) Low isolation rates

ii) Comparison of cell lines

iii) Vendor changes

iv) Proficiency test failures

v) Training purposes

vi) Consistent problems with negative controls

vii) Preparation of QC material (i.e. Positive control slides)

Consult a senior technologist to determine the cell lines and viruses to be set up.

II. Shell Vial Cell Line (Suspension seeding is not in routine use)

Upon receipt of a shipment of cells, initial and date the record sheet accompanying the shipment. The record should contain vendor, lot number, passage number and QC data. File in the QC binder for cell lines.

Before seeding the shell vials, aspirate about 30 mL of MRC-5 cell suspension into a 125 cm2 tissue culture flask, label on the side of flask with “MRC-5, date and ‘Pre’”.

After seeding shell vials, aspirate about 30 mL of MRC-5 cell suspension into another 125 cm2 tissue culture flask, label on the side of flask with “MRC-5, date and ‘Post’”.

Reserve 6 shell vials for use as negative and positive controls as follows:

 

A. Negative Controls for this week, also become Positive Old Lot for following week (3 Vials)

These are incubated at 36oC and observed daily for one week or more to identify toxicity and contamination originating with the vendor. Results are recorded on the QC chart.

Three shell vials are reserved to QC the next shipment in parallel after the cells are added.

 

B. Positive Controls (3 Vials)

Each week, usually 2-3 days after seeding the shell vials, HFF tubes containing HSV-1 (ATCC VR-5539), HSV-2 (ATCC VR-540) and CMV (ATCC VR-807) are scraped from and used to inoculate 6 MRC-5 shell vials, 3 from the current lot and 3 from the previous lot (the same 3 vials were used as Negative Controls for a week). The shell vials are then stained with HSV-1, HSV-2 and CMV IEA monoclonal antibodies after 1 day incubation. Record the results into the LIS daily QC under the following codes:

a. VHSV1D HSV1 daily SLIDE SV QC

b. VHSV1D HSV1 daily SLIDE SV QC

c. VCMV-D CMV-IE daily SLIDE SV QC

d. VQCSV Shell Vial MRC-5 Quality Control


BAHAN KULIAH DAN MAKALAH KESEHATAN : http://bahankuliahkesehatan.blogspot.com/2011/08/appendix-xiii-preservation-of-cell.html

Appendix XVII VIROLOGY TRAINING GUIDE (optional) & Appendix XVIII QUALITY CONTROL OF MONOCLONAL ANTIBODIES

 

WEEK

ACTIVITY

MATERIALS

1

SHELL VIAL UNKNOWNS

CMV / HHF

HSV / HHF

1 - 2

TUBE CULTURE UNKNOWNS

CMV / HHF

HSV / HHF

ECHOVIRUS / HHF, RMK, HEP-2

COXSACKIE B / HHF, RMK, HEP-2

ADENOVIRUS / HFF, RMK, HEP-2

*INFLUENZA A / HHF, RMK, HEP-2

*PARAINFLUENZA 3 / HHF, RMK, HEP-2

*RSV / HHF, RMK, HEP-2

START 1ST WEEK

SPECIMEN PLANTING

PATIENT SAMPLES

START 2ND WEEK

SHELL VIAL STAINING

PATIENT SAMPLES

START 3RD WEEK

TUBE CULTURE READING

PATIENT SAMPLES

1 - 8

READ LAP - 1, 2, 3

CACMILE SELF-STUDY

VIROLOGY COURSE

8 (END OF ROTATION)

WRITTEN EXCERCISES /

SELF-EXAM

CACMILE SELF-STUDY

VIROLOGY COURSE

*November to April training periods only.

 

Appendix XVIII

QUALITY CONTROL OF MONOCLONAL ANTIBODIES

Monoclonal Antibodies

Method

Expected Use

Respiratory Viral Screen/RSV panel

FluA/B panel

RSV/para3 panel

Para123/Adeno panel

Specific Parainfluenza 1

Specific Parainfluenza 2

SimulFluor DFA

SimulFluor DFA

SimulFluor DFA

SimulFluor DFA

DFA

DFA

R-Mix Shell Vials / direct specimen

Coxsackie A9

Coxsackie B

Echovirus

Poliovirus

Enterovirus 70 / 71

Mumps (not in routine use)

IFA

E-Mix /MRC-5 Shell Vials

CMV pp65

CMV Immediate Early

IFA

IFA

Direct polymorph, leukocytes

MRC-5 Shell Vial

Specific Herpes simplex 1

Specific Herpes simplex 2

Specific Varicella zoster virus

CMV early & late

Herpes simplex bivalent

DFA

MRC-5 Shell Vial /direct specimen

MRC-5 Shell Vial /direct specimen

MRC-5 Shell Vial /direct specimen

MRC-5 Shell Vial

MRC-5 Shell Vial /direct specimen

http://bahankuliahkesehatan.blogspot.com/


BAHAN KULIAH DAN MAKALAH KESEHATAN : http://bahankuliahkesehatan.blogspot.com/2011/08/appendix-xvii-virology-training-guide.html

Appendix XVIII (Cont'd) QUALITY CONTROL OF MONOCLONAL ANTIBODIES

Reagent quality controls:

These must be perform prior to patient testing to ensure each component of the reagent performs as expected.

a. Check expiratory date then perform DFA, SimulFlour DFA or IFA accordingly.

b. External QC slides (different manufacturer, unless not available) of the same batch are used to test both current and the new reagents in parallel

c. Results must fall within range of expected results before reagents are released for use (eg. all 7 viruses must be positive and negative wells are negative for the Bion 14-well Respiratory Panel).

d. Record reagent expiry date and QC results in Reagent Log and/or LIS.

e. Report abnormal QC results to Charge/Senior technologist.

http://bahankuliahkesehatan.blogspot.com/

 

Expected reagent QC results:

External (commercial) QC slide

Current Reagent

New Reagent

Positive well

(for each virus)

+

+

(no weaker than current reagent)

Negative well

-

-

Failed reagent QC results:

i. Inform charge/senior technologist to investigate cause of failed QC.

ii. Record in Reagent Log Chart. (Instrument Maintenance Log if microscope/incubator is involved in the failure and Incident Report if necessary).

iii. May need to re-run failed control materials in parallel to fresh controls to evaluate the QC material itself.

iv. If the re-run shows the old QC material still fails and fresh QC is satisfactory, the error may be attributed to the old QC material itself and the reagent is satisfactory.

v. If the re-run shows both the old and fresh QC material fail (or other QC not satisfactory), the error may be attributed to the reagent then the reagent cannot be released for use. Supplier of the reagent should be contacted and the appropriate incident report should be filled.

 

Daily QCs:

These are performed within each batch of patient samples to monitor assay performance and techniques within the batch.

a. Check reagent expiratory date and verify that Reagent QC is satisfactory for the reagent lot/kit being used.

b. Appropriate positive and negative control slides (eg. ATCC 4-well slide with RSV/Para3 for SimulF RS stain) should be stained with each batch. These slides should be placed in various random positions within the batch.

c. Examine the negative control well first to establish the dull red colour (Evans blue counterstained) and to determine if there is any nonspecific staining.

The positive control must be clearly distinguishable from the negative control or the test is invalid.

d. Record QC results in LIS and/or wosksheet.

Failed Daily QC:

i. Do not release patient results pending resolution of QC error.

ii. Inform charge/senior technologist.

iii. Record in Reagent Log Chart (and Instrument Maintenance Log if microscope/incubator is involved in the failure).

iv. Re-run failed controls in parallel to fresh controls (and/or external QC) to evaluate the QC material itself.

v. If the re-run shows the old QC material still fails, fresh QC passes and nothing else is wrong with the batch (only the old QC material failed, patient results valid) patient results may be released.

 

Marked decrease/absence in fluorescence can be due to:

a. Reagent deterioration/skipping (did not apply primary/secondary stain)

b. Microscope (filter, bulb, alignment)

c. Other equipment, reagents or technique

http://bahankuliahkesehatan.blogspot.com/


BAHAN KULIAH DAN MAKALAH KESEHATAN : http://bahankuliahkesehatan.blogspot.com/2011/08/appendix-xviii-cont-quality-control-of.html